Magda Marquet

1.1k total citations
16 papers, 875 citations indexed

About

Magda Marquet is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Magda Marquet has authored 16 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Oncology. Recurrent topics in Magda Marquet's work include RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (5 papers) and Bacterial Genetics and Biotechnology (3 papers). Magda Marquet is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (5 papers) and Bacterial Genetics and Biotechnology (3 papers). Magda Marquet collaborates with scholars based in France, United States and Czechia. Magda Marquet's co-authors include Jennifer Meek, Nancy A. Horn, Marston Manthorpe, Jon Norman, Peter Hobart, M Margalith, Jukka Hartikka, Michael Sawdey, H. Lee Vahlsing and Kerry M. Barnhart and has published in prestigious journals such as The Lancet, Nature Biotechnology and Biochemistry.

In The Last Decade

Magda Marquet

16 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magda Marquet France 12 583 309 166 141 107 16 875
Mohamed El Khattabi Netherlands 17 629 1.1× 135 0.4× 121 0.7× 91 0.6× 75 0.7× 27 1.0k
Bernard de Geus Netherlands 11 753 1.3× 84 0.3× 424 2.6× 83 0.6× 171 1.6× 24 1.3k
Mehdi Arbabi‐Ghahroudi Canada 19 792 1.4× 100 0.3× 310 1.9× 162 1.1× 156 1.5× 31 1.3k
Susanne Bauer Germany 13 353 0.6× 208 0.7× 151 0.9× 163 1.2× 123 1.1× 25 879
Sandrine Audouy Netherlands 11 456 0.8× 174 0.6× 119 0.7× 64 0.5× 156 1.5× 13 861
Gary F. Gerard United States 18 926 1.6× 317 1.0× 112 0.7× 123 0.9× 249 2.3× 35 1.4k
Wolfgang Jechlinger Austria 17 354 0.6× 214 0.7× 242 1.5× 294 2.1× 100 0.9× 21 806
Julie A. Lovchik United States 19 585 1.0× 247 0.8× 136 0.8× 169 1.2× 407 3.8× 31 1.1k
Denise Lew United States 10 673 1.2× 526 1.7× 536 3.2× 39 0.3× 149 1.4× 11 1.3k
David P. Humphreys United Kingdom 21 882 1.5× 424 1.4× 152 0.9× 490 3.5× 142 1.3× 38 1.4k

Countries citing papers authored by Magda Marquet

Since Specialization
Citations

This map shows the geographic impact of Magda Marquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Marquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Marquet more than expected).

Fields of papers citing papers by Magda Marquet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Marquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Marquet. The network helps show where Magda Marquet may publish in the future.

Co-authorship network of co-authors of Magda Marquet

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Marquet. A scholar is included among the top collaborators of Magda Marquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Marquet. Magda Marquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hartikka, Jukka, et al.. (2003). Development and Characterization of Lyophilized DNA Vaccine Formulations. Humana Press eBooks. 29. 23–34. 2 indexed citations
2.
3.
Marquet, Magda, Nancy A. Horn, Jennifer Meek, & S Pestka. (1996). Process development for the manufacture of plasmid DNA vectors for use in gene therapy. 20(4). 28–46. 31 indexed citations
4.
Soriano, G. M., et al.. (1996). High-Yield Production of pBR322-Derived Plasmids Intended for Human Gene Therapy by Employing a Temperature-Controllable Point Mutation. Human Gene Therapy. 7(16). 1971–1980. 71 indexed citations
5.
Hartikka, Jukka, Michael Sawdey, M Margalith, et al.. (1996). An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle. Human Gene Therapy. 7(10). 1205–1217. 280 indexed citations
6.
Parker, Suezanne E., M Margalith, Michelle A. Yankauckas, et al.. (1996). Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.. PubMed. 3(3). 175–85. 42 indexed citations
7.
Horn, Nancy A., et al.. (1995). Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials. Human Gene Therapy. 6(5). 565–573. 194 indexed citations
8.
Nabel, Gary J., Zhi-Yong Yang, Elizabeth G. Nabel, et al.. (1995). Direct Gene Transfer for Treatment of Human Cancer. Annals of the New York Academy of Sciences. 772(1). 227–231. 27 indexed citations
9.
Carvallo, D., Alain Van Dorsselaer, Magda Marquet, et al.. (1989). Purification and biochemical characterization of recombinant hirudin produced by Saccharomyces cerevisiae. Biochemistry. 28(7). 2941–2949. 49 indexed citations
10.
Marquet, Magda, Marcia Mikolajczak, Linda Thorne, & Thomas J. Pollock. (1989). Improved strains for production of xanthan gum by fermentation ofXanthomonas campestris. Journal of Industrial Microbiology & Biotechnology. 4(1). 55–64. 19 indexed citations
11.
Loison, G., Annie Findeli, Magda Marquet, et al.. (1988). Expression and Secretion in S. Cerevisiae of Biologically Active Leech Hirudin. Nature Biotechnology. 6(1). 72–77. 65 indexed citations
12.
Courtney, Michael, G. Loison, Paul Tolstoshev, et al.. (1987). The production and evaluation of recombinant hirudin. Thrombosis Research. 45. 30–30. 1 indexed citations
13.
14.
Loison, Gérard, et al.. (1986). Plasmid–Transformed ura3 fur1 Double-Mutants of S. cerevisiae: An Autoselection System Applicable to the Production of Foreign Proteins. Nature Biotechnology. 4(5). 433–437. 45 indexed citations
15.
Marquet, Magda, Sami Alouani, & Stephen Brown. (1986). Plasmid stability during continuous culture in aSaccharomyces cerevisiae double mutant transformed by a plasmid carrying a eukaryotic gene. Biotechnology Letters. 8(8). 535–540. 7 indexed citations
16.
Sultan, C. & Magda Marquet. (1975). COLONY-STIMULATING CAPACITY OF CELLS OF HAIRY-CELL LEUKÆMIA. The Lancet. 305(7912). 920–920. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed El Khattabi Breakdown of academic impact, for papers by Bernard de Geus Breakdown of academic impact, for papers by Mehdi Arbabi‐Ghahroudi Breakdown of academic impact, for papers by Susanne Bauer Breakdown of academic impact, for papers by Sandrine Audouy Breakdown of academic impact, for papers by Gary F. Gerard Breakdown of academic impact, for papers by Wolfgang Jechlinger Breakdown of academic impact, for papers by Julie A. Lovchik Breakdown of academic impact, for papers by Denise Lew Breakdown of academic impact, for papers by David P. Humphreys
Rankless by CCL
2026